MannKind gets cash infusion from United Therapeutics

You are here: Home > Central Coast Health Watch > Current Article

MannKind gets cash infusion from United Therapeutics

By Marissa Nall / Tuesday, September 4th, 2018 / Comments Off on MannKind gets cash infusion from United Therapeutics

Not many biotech executives could coolly assure investors that they wouldn’t see further dilution as they stared down the barrel of bankruptcy. Just weeks from tripping over a $20 million cash threshold with its creditors, Westlake Village-based MannKind announced that it had secured a deal that would deliver a $45 million infusion of capital and…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.